Nucleosides

2'-Modified Nucleosides
(288/288)
3'-Modified Nucleosides
(157/157)
5'-Modified Nucleosides
(236/236)
Anhydro-Nucleosides
(13/13)
Arabinonucleosides
(34/34)
Base Protected Nucleosides
(224/224)
Halogen Nucleosides
(134/134)
L-Nucleosides
(18/18)
Other Nucleosides
(77/77)
Other Protected Nucleosides
(23/23)
Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

5'-O-DMT-N2-isobutyryl-2'-O-propargylguanosine

Description: 5'-O-DMT-N2-isobutyryl-2'-O-propargylguanosine is an advanced compound prescribed for research of viral infections, demonstrating inhibitory efficacy by selectively targeting specific RNA viruses. Employing a potent mechanism of inhibiting viral replication and considerably attenuating viral loads, this compound exhibits promising potential in the research of RNA virus-induced ailments such as influenza and hepatitis C.
CAT: BRP-01636
CAS: 171486-53-6
MF: C38H39N5O8
MF: 693.74
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.31±0.1 g/cm3
InChIKey: ZTBYTNLGRCUAEU-BEGXHNNXSA-N
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OCC#C
IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-prop-2-ynoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
InChI: InChI=1S/C38H39N5O8/c1-6-20-49-32-31(44)29(51-36(32)43-22-39-30-33(43)40-37(42-35(30)46)41-34(45)23(2)3)21-50-38(24-10-8-7-9-11-24,25-12-16-27(47-4)17-13-25)26-14-18-28(48-5)19-15-26/h1,7-19,22-23,29,31-32,36,44H,20-21H2,2-5H3,(H2,40,41,42,45,46)/t29-,31-,32-,36-/m1/s1
Synonyms: N2-iBu-5'-O-(4,4'-dimethoxytrityl)-2'-O-propargyl-guanosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-2-propyn-1-yl-Guanosine; N2-iBu-DMT-2'-O-propargyl-Gr; N2-iso-Butyroyl-5'-(4,4'-dimethoxytrityl)-2'-O-propargylguanosine; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-N-isobutyryl-2'-O-2-propyn-1-ylguanosine; Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-2-propynyl-

5'-O-DMT-2'-O-Propargyl-Uridine

Description: 5'-O-DMT-2'-O-Propargyl-Uridine, a nucleoside analog commonly used for cancer therapy, serves as a potent inhibitor of nucleic acid synthesis, thus holding the capacity to trigger cell death upon incorporation with DNA of cancerous cells. Such an enticing compound is marked with potential therapeutic benefits for patients suffering from leukemia and lymphoma, thereby marking a boon for the medical fraternity in tackling cancer at its core.
CAT: BRP-01637
CAS: 171486-54-7
MF: C33H32N2O8
MF: 584.63
Purity: ≥97% by HPLC
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.35±0.1 g/cm3
InChIKey: VFYMBSPPKISNAZ-PMFUCWTESA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)OCC#C)O
IUPAC Name: 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
InChI: InChI=1S/C33H32N2O8/c1-4-20-41-30-29(37)27(43-31(30)35-19-18-28(36)34-32(35)38)21-42-33(22-8-6-5-7-9-22,23-10-14-25(39-2)15-11-23)24-12-16-26(40-3)17-13-24/h1,5-19,27,29-31,37H,20-21H2,2-3H3,(H,34,36,38)/t27-,29-,30-,31-/m1/s1
Synonyms: 5'-O-(4,4'-dimethoxytrityl)-2'-O-propargyl-uridine; 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; DMT-2'-O-propargyl-Ur; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-2-propyn-1-yl-; 5-O-(4,4'-dimethoxytrityl)-1-deoxy-2-O-prop-2-ynyl-1-uracil-1-yl-beta-D-ribo-pentofuranose; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-2-propyn-1-yluridine

N4-Benzoyl-5'-O-DMT-2'-O-propargyl adenosine

Description: N4-Benzoyl-5'-O-DMT-2'-O-propargyl adenosine stands as an influential and efficacious compound widely employed in the research of ailments, encompassing cancers and viral infections.
CAT: BRP-01638
CAS: 171486-51-4
MF: C41H37N5O7
MF: 711.76
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.29±0.1 g/cm3
InChIKey: HJXHRBGNFZRNDJ-MUMPVVMASA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)NC(=O)C7=CC=CC=C7)OCC#C)O
IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-prop-2-ynoxyoxolan-2-yl]purin-6-yl]benzamide
InChI: InChI=1S/C41H37N5O7/c1-4-23-51-36-35(47)33(53-40(36)46-26-44-34-37(42-25-43-38(34)46)45-39(48)27-11-7-5-8-12-27)24-52-41(28-13-9-6-10-14-28,29-15-19-31(49-2)20-16-29)30-17-21-32(50-3)22-18-30/h1,5-22,25-26,33,35-36,40,47H,23-24H2,2-3H3,(H,42,43,45,48)/t33-,35-,36-,40-/m1/s1
Synonyms: N6-Bz-5'-O-(4,4'-dimethoxytrityl)-2'-O-propargyl-adenosine; N6-Bz-DMT-2'-O-propargyl-Ar; N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(propyn-1-yl)adenosine; N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-propargyl adenosine; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-2-propyn-1-yladenosine; N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide

5'-O-DMT-cytidine

Description: 5'-O-DMT-cytidine is a highly influential and extensively utilized component, having extraordinary aptitude as a remarkable countermeasure against both DNA and RNA viral compounds. Profoundly indispensable in the confrontment of pernicious viral afflictions, such as herpes simplex, HIV and hepatitis, this exalted compound exhibits an unparalleled capability in suppressing viral replication.
CAT: BRP-01639
CAS: 112897-99-1
MF: C30H31N3O7
MF: 545.58
Purity: ≥95%
Appearance: Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.34 g/cm3
Boiling Point: 742.5±70.0°C at 760 mmHg
InChIKey: SUENBDLQORXVMC-YULOIDQLSA-N
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=NC5=O)N)O)O
IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C30H31N3O7/c1-37-22-12-8-20(9-13-22)30(19-6-4-3-5-7-19,21-10-14-23(38-2)15-11-21)39-18-24-26(34)27(35)28(40-24)33-17-16-25(31)32-29(33)36/h3-17,24,26-28,34-35H,18H2,1-2H3,(H2,31,32,36)/t24-,26-,27-,28-/m1/s1
Synonyms: 5'-O-(4,4'-Dimethoxytrityl)cytidine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]cytidine; 4-Amino-1-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyrimidin-2(1H)-one; DMT-Cr

5-Iodo-2'-O-methylcytidine

Description: 5-Iodo-2'-O-methylcytidine, a nucleoside analogue (NSA), is a chemotherapeutic agent that induces neuronal differentiation.
CAT: BRP-01640
CAS: 847650-69-5
MF: C10H14IN3O5
MF: 383.14
Purity: ≥95%
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C, Keep in a dark and dry place
Density: 2.24±0.1 g/cm3
Boiling Point: 533.0±60.0°C at 760 mmHg
InChIKey: JQWRBXTVVLSBBM-JXOAFFINSA-N
CanonicalSMILES: COC1C(C(OC1N2C=C(C(=NC2=O)N)I)CO)O
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-iodopyrimidin-2-one
InChI: InChI=1S/C10H14IN3O5/c1-18-7-6(16)5(3-15)19-9(7)14-2-4(11)8(12)13-10(14)17/h2,5-7,9,15-16H,3H2,1H3,(H2,12,13,17)/t5-,6-,7-,9-/m1/s1
Synonyms: 5-Iodo-2'-O-methyl-cytidine; 5-I-2'-O-Me-Cr; Cytidine, 5-iodo-2'-O-methyl-; 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-iodopyrimidin-2(1H)-one

3'-O-Propargylguanosine

Description: 3'-O-Propargylguanosine, a widely utilized biomedicine product, has gained significant attention as a valuable tool in academic research for exploring diverse cellular processes. Serving as a modified guanosine nucleotide, it exhibits the ability to be seamlessly integrated into RNA molecules during the transcriptional phase. By leveraging this product, researchers can delve deep into the intricate realm of RNA biology, meticulously examining its structural composition, synthetic mechanisms, and functional aspects.
CAT: BRP-01641
CAS: 1429494-08-5
MF: C13H15N5O5
MF: 321.29
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.76±0.1 g/cm3
Boiling Point: 737.5±70.0 °C at 760 mmHg
InChIKey: XJXNRNJCUMEGAU-WOUKDFQISA-N
CanonicalSMILES: C#CCOC1C(OC(C1O)N2C=NC3=C2N=C(NC3=O)N)CO
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-ynoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C13H15N5O5/c1-2-3-22-9-6(4-19)23-12(8(9)20)18-5-15-7-10(18)16-13(14)17-11(7)21/h1,5-6,8-9,12,19-20H,3-4H2,(H3,14,16,17,21)/t6-,8-,9-,12-/m1/s1
Synonyms: 3'-O-propargyl-guanosine; 2-amino-9-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one; 3'-O-2-Propyn-1-ylguanosine; 3'-Propargylguanosine; 3'-O-propargyl-Gr; 3'-O-Propargyl-D-guanosine; 3'-(O-propargyl) Guanosine

2-Amino-2'-O-(2-propyn-1-yl)adenosine

Description: 2-Amino-2'-O-(2-propyn-1-yl)adenosine is an adenosine receptor agonist capable of orchestrating and redefining the intricate web of cellular signaling pathways.
CAT: BRP-01642
CAS: 1451256-04-4
MF: C13H16N6O4
MF: 320.30
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.8±0.1 g/cm3
Boiling Point: 757.8±70.0°C at 760 mmHg
InChIKey: AGYDCNMIAHDTSH-WOUKDFQISA-N
CanonicalSMILES: C#CCOC1C(C(OC1N2C=NC3=C(N=C(N=C32)N)N)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)-4-prop-2-ynoxyoxolan-3-ol
InChI: InChI=1S/C13H16N6O4/c1-2-3-22-9-8(21)6(4-20)23-12(9)19-5-16-7-10(14)17-13(15)18-11(7)19/h1,5-6,8-9,12,20-21H,3-4H2,(H4,14,15,17,18)/t6-,8-,9-,12-/m1/s1
Synonyms: 2'-O-propargyl-2-amino-adenosine; 2'-O-propargyl-2-amino-Ar; 2'-O-Propygyl-2-aminoadenosine; Adenosine, 2-amino-2'-O-2-propyn-1-yl-; 9-(2-O-Propargyl-beta-D-ribofuranosyl)-9H-purine-2,6-diamine; (2R,3R,4R,5R)-5-(2,6-Diamino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-3-ol; 2-Amino-2'-O-2-propyn-1-yladenosine

5'-Deoxy-5'-fluorouridine

Description: 5'-Deoxy-5'-fluorouridine is a modified nucleoside lacking the 5'-hydroxyl group of uridine and substituted with a fluorine atom. This compound is utilized in biochemical and pharmaceutical research as an antiviral and anticancer agent. It can be incorporated into RNA during transcription, altering RNA structure and function. Studying its effects helps understand RNA biology and explore potential therapeutic applications.
CAT: BRP-01643
CAS: 38817-29-7
MF: C9H11FN2O5
MF: 246.19
Purity: 95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.601±0.06 g/cm3
Melting Point: 141-142 °C
InChIKey: JIWIXZJAAUQOCE-XVFCMESISA-N
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CF)O)O
IUPAC Name: 1-[(2R,3R,4S,5S)-5-(fluoromethyl)-3,4-dihydroxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11FN2O5/c10-3-4-6(14)7(15)8(17-4)12-2-1-5(13)11-9(12)16/h1-2,4,6-8,14-15H,3H2,(H,11,13,16)/t4-,6-,7-,8-/m1/s1
Synonyms: 5'-fluoro-uridine; 5'-F-Ur; 1-((2R,3R,4S,5S)-5-(fluoromethyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 5'-DFUR; 5'-Deoxy-5-fluorouridine; 5'-Fluorodeoxyuridine; NSC 524310

3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)guanosine

Description: 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)guanosine is a vital compound used in the biomedical industry. It acts as a crucial building block in the synthesis of RNA and DNA molecules, playing a significant role in gene expression and regulation. This compound finds utility in research related to nucleic acids, drug discovery, and the development of treatments targeting diseases such as cancer and viral infections.
CAT: BRP-01677
CAS: 69304-44-5
MF: C22H39N5O6Si2
MF: 525.76
Purity: ≥98%
Appearance: White to off-white crystalline powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.36±0.1 g/cm3
Melting Point: >260 °C
InChIKey: CWVNMKRKFJYCCC-QTQZEZTPSA-N
CanonicalSMILES: CC(C)[Si]1(OCC2C(C(C(O2)N3C=NC4=C3N=C(NC4=O)N)O)O[Si](O1)(C(C)C)C(C)C)C(C)C
IUPAC Name: 9-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-amino-1H-purin-6-one
InChI: InChI=1S/C22H39N5O6Si2/c1-11(2)34(12(3)4)30-9-15-18(32-35(33-34,13(5)6)14(7)8)17(28)21(31-15)27-10-24-16-19(27)25-22(23)26-20(16)29/h10-15,17-18,21,28H,9H2,1-8H3,(H3,23,25,26,29)/t15-,17-,18-,21-/m1/s1
Synonyms: 3',5'-O-(Tetraisopropyldisiloxane-1,3-diyl)-guanosine; 3',5'-TIPDS-Gr; 3',5'-O-TIPPS-guanosine; 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disoloxanediyl-D-guanosine; 3',5'-O-[1,1,3,3-Tetrakis(1-methylethyl)-1,3-disiloxanediyl]guanosine; 3',5'-TIPS-guanosine

3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine

Description: 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)cytidine, a nucleoside analogue drug, acts as an inhibitor of viral replication to alleviate hepatitis B and C. With its action aimed at blocking reverse transcriptase, the virus loses its ability to propagate. Besides being effective against these chronic infections, the drug has exhibited encouraging results in combatting cancerous cells and HIV.
CAT: BRP-01678
CAS: 69304-42-3
MF: C21H39N3O6Si2
MF: 485.72
Purity: ≥95% by HPLC
Appearance: White to off-white crystalline powder
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.24±0.1 g/cm3
Melting Point: 248-250 °C
Boiling Point: 517.7±60.0 °C at 760 mmHg
InChIKey: KPNSXQNKDQMBAW-VBSBHUPXSA-N
CanonicalSMILES: CC(C)[Si]1(OCC2C(C(C(O2)N3C=CC(=NC3=O)N)O)O[Si](O1)(C(C)C)C(C)C)C(C)C
IUPAC Name: 1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-4-aminopyrimidin-2-one
InChI: InChI=1S/C21H39N3O6Si2/c1-12(2)31(13(3)4)27-11-16-19(29-32(30-31,14(5)6)15(7)8)18(25)20(28-16)24-10-9-17(22)23-21(24)26/h9-10,12-16,18-20,25H,11H2,1-8H3,(H2,22,23,26)/t16-,18-,19-,20-/m1/s1
Synonyms: 3',5'-O-(Tetraisopropyldisiloxane-1,3-diyl)-cytidine; 3',5'-TIPDS-Cr; 3',5'-TIPS-cytidine; 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-D-cytidine; 3',5'-O-[1,1,3,3-Tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine

Fludarabine

Description: Arabinofuranosyl-2-fluoro-adenin is an adenosine deaminase resistant analog of 9-β-D-arabinofuranosyladenine (ara-A) that inhibits DNA synthesis. It is commonly used as an antitumor agent for its antiproliferative property.
CAT: BRP-01682
CAS: 21679-14-1
MF: C10H12FN5O4
MF: 285.23
Purity: ≥95%
Appearance: White to Off-white Crystals
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 2.17±0.1 g/cm3 (Predicted)
Melting Point: >256°C (dec.)
Boiling Point: 747.3±70.0°C (Predicted)
Flash Point: 405.8°C
Application: Antineoplastic Agents
InChIKey: HBUBKKRHXORPQB-FJFJXFQQSA-N
Solubility: Soluble in DMF, DMSO, Methanol, Ethanol, Water (Sparingly)
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F
IUPAC Name: (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6+,9-/m1/s1
Synonyms: 2-F-Ara-Ar; 2-Fluoro-arabinoadenosine; 9-(β-D-Arabinofuranosyl)-2-fluoroadenine; F-ara-A; NSC 118218; (2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2-fluoro-9-β-D-arabinofuranosyladenine
Related CAS: 75607-67-9 ; (phosphate)

2'-O-Allyladenosine

Description: 2'-O-Allyladenosine is a compound of great significance in the realm of biomedical science and industry, finding profound applications in the domain of antiviral therapeutics, particularly in studying the pernicious RNA viruses.
CAT: BRP-01693
CAS: 133766-26-4
MF: C13H17N5O4
MF: 307.31
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.66±0.1 g/cm3
Boiling Point: 632.8±65.0 °C at 760 mmHg
InChIKey: DUQRPQVBZQQZPL-QYVSTXNMSA-N
CanonicalSMILES: C=CCOC1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-prop-2-enoxyoxolan-3-ol
InChI: InChI=1S/C13H17N5O4/c1-2-3-21-10-9(20)7(4-19)22-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h2,5-7,9-10,13,19-20H,1,3-4H2,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1
Synonyms: 2'-(O-allyl) Adenosine; 2'-O-Allyl-D-adenosine; 2'-O-2-Propenyladenosine; (2R,3R,4R,5R)-4-(allyloxy)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

2'-O-Allylguanosine

Description: 2'-O-Allylguanosine is a nucleoside derivative widely employed in the realm of biomedical research, boasting immense potential for the development of antiviral medications, inclusive of therapeutic solutions targeting HIV, hepatitis C, and sundry viral afflictions.
CAT: BRP-01694
CAS: 133766-28-6
MF: C13H17N5O5
MF: 323.30
Purity: 95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.77±0.1 g/cm3
InChIKey: XCAPQNAAANDMJX-WOUKDFQISA-N
CanonicalSMILES: C=CCOC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)CO)O
IUPAC Name: 2-amino-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-enoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C13H17N5O5/c1-2-3-22-9-8(20)6(4-19)23-12(9)18-5-15-7-10(18)16-13(14)17-11(7)21/h2,5-6,8-9,12,19-20H,1,3-4H2,(H3,14,16,17,21)/t6-,8-,9-,12-/m1/s1
Synonyms: 2'-(O-allyl) Guanosine; 2'-O-Allyl-D-guanosine; 9-((2R,3R,4R,5R)-3-(Allyloxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-amino-1H-purin-6(9H)-one; 2'-O-2-Propen-1-ylguanosine

2'-O-Allyluridine

Description: 2'-O-Allyluridine, a potent biomedical compound renowned for its efficacy in combating viral infections, such as hepatitis C and herpes simplex, emerges as a pivotal therapeutic agent. Its unrivaled antiviral attributes empower it to effectively impede viral replication. Notably esteemed, this compound has secured its place within numerous esteemed research databases, unveiling valuable insights into its chemical properties and synthesis methodologies, prevalently furnished by reputable chemical sources.
CAT: BRP-01695
CAS: 133766-24-2
MF: C12H16N2O6
MF: 284.27
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.45±0.1 g/cm3
InChIKey: NGZRTPYYZWYZSO-QCNRFFRDSA-N
CanonicalSMILES: C=CCOC1C(C(OC1N2C=CC(=O)NC2=O)CO)O
IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-enoxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C12H16N2O6/c1-2-5-19-10-9(17)7(6-15)20-11(10)14-4-3-8(16)13-12(14)18/h2-4,7,9-11,15,17H,1,5-6H2,(H,13,16,18)/t7-,9-,10-,11-/m1/s1
Synonyms: 2'-O-Allyl-D-uridine; 2'-(O-allyl) Uridine; 2'-O-2-Propen-1-yluridine

5-(1-Propynyl)-2'-O-methyluridine

Description: 5-(1-Propynyl)-2'-O-methyluridine is a remarkable potent antiviral compound acting as an expert inhibitor of RNA viruses, boasting an ability to curb the notorious influenza virus.
CAT: BRP-01699
CAS: 179817-95-9
MF: C13H16N2O6
MF: 296.28
Purity: ≥97%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.48±0.1 g/cm3
InChIKey: KPJZKNCZUWDUIF-DNRKLUKYSA-N
CanonicalSMILES: CC#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)OC
IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione
InChI: InChI=1S/C13H16N2O6/c1-3-4-7-5-15(13(19)14-11(7)18)12-10(20-2)9(17)8(6-16)21-12/h5,8-10,12,16-17H,6H2,1-2H3,(H,14,18,19)/t8-,9-,10-,12-/m1/s1
Synonyms: 5-Propynyl-2'-(O-Methyl) Uridine; 1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-(prop-1-yn-1-yl)pyrimidine-2,4(1H,3H)-dione; 2'-O-Methyl-5-prop-1-yn-1-yluridine; 2'-O-Methyl-5-propynyluridine

5-(1-Propynyl)-2'-O-methylcytidine

Description: 5-(1-Propynyl)-2'-O-methylcytidine is a robust and efficacious antiviral compound, finding profound utility in the research of various virological malaises such as respiratory syncytial virus (RSV), influenza and hemorrhagic fever viruses. Its mechanism of action lies in thwarting viral replication and averting viral dissemination within the host organism.
CAT: BRP-01700
CAS: 179817-96-0
MF: C13H17N3O5
MF: 295.29
Purity: ≥95%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.47±0.1 g/cm3
Boiling Point: 522.4±60.0 °C at 760 mmHg
InChIKey: RDNYOZGTGXUIIY-DNRKLUKYSA-N
CanonicalSMILES: CC#CC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)OC
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one
InChI: InChI=1S/C13H17N3O5/c1-3-4-7-5-16(13(19)15-11(7)14)12-10(20-2)9(18)8(6-17)21-12/h5,8-10,12,17-18H,6H2,1-2H3,(H2,14,15,19)/t8-,9-,10-,12-/m1/s1
Synonyms: 5-Propynyl-2'-(O-Methyl) Cytidine; Cytidine, 2'-O-methyl-5-(1-propynyl)-; 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-(prop-1-yn-1-yl)pyrimidin-2(1H)-one; 2'-O-Methyl-5-prop-1-yn-1-ylcytidine

3'-O-Allyladenosine

Description: 3'-O-Allyladenosine, a vital compound in the field of biomedicine, serves as a fundamental element for investigating adenosine receptors. These receptors, implicated in a multitude of ailments encompassing cardiovascular disorders, immunological responses, and neurodegenerative afflictions, hold great importance. This particular product is frequently employed to delve into the potential therapeutic applications of adenosine receptor modulation, specifically targeting conditions like ischemic heart disease, asthma, and malignancies.
CAT: BRP-01701
CAS: 400820-99-7
MF: C13H17N5O4
MF: 307.31
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
Density: 1.66±0.1 g/cm3
Boiling Point: 632.8±65.0 °C at 760 mmHg
InChIKey: KURUYHOEDIRMCE-QYVSTXNMSA-N
CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO
IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-3-ol
InChI: InChI=1S/C13H17N5O4/c1-2-3-21-10-7(4-19)22-13(9(10)20)18-6-17-8-11(14)15-5-16-12(8)18/h2,5-7,9-10,13,19-20H,1,3-4H2,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1
Synonyms: 3'-O-Allyl-D-adenosine; 3'-(O-allyl) Adenosine; 3'-O-allyl Adenosine; (2R,3R,4S,5R)-4-(allyloxy)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol; 3'-O-2-Propen-1-yladenosine

3'-O-Allylguanosine

Description: 3'-O-Allylguanosine, a widely used biomedicine product in research, presents itself as a paramount avenue to explore the antiviral properties exhibited by guanosine derivatives. Its prominent role extends to serving as a pivotal reference compound, wherein its efficacy in combating viral infections, namely HIV, hepatitis, and respiratory viruses, can be meticulously evaluated.
CAT: BRP-01702
MF: C13H17N5O5
MF: 323.30
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: XCRVSUORBIBONA-WOUKDFQISA-N
CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=NC3=C2N=C(NC3=O)N)CO
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C13H17N5O5/c1-2-3-22-9-6(4-19)23-12(8(9)20)18-5-15-7-10(18)16-13(14)17-11(7)21/h2,5-6,8-9,12,19-20H,1,3-4H2,(H3,14,16,17,21)/t6-,8-,9-,12-/m1/s1
Synonyms: 3'-(O-allyl) Guanosine; 3'-O-Allyl-D-guanosine; 9-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-amino-1,9-dihydro-6H-purin-6-one

3'-O-Allyluridine

Description: 3'-O-Allyluridine, a vital compound extensively employed in the biomedical sector, plays a pivotal role in combating diverse ailments. Brimming with extraordinary antiviral and anticancer attributes, this remarkable entity boasts immense worth in the realm of antiviral medications and chemotherapeutic agents. With its profound ability to specifically target and impede the replication of both viruses and malignant cells, this compound unfurls a vast array of prospects for potential therapeutic interventions against viral infections and neoplastic disorders.
CAT: BRP-01703
MF: C12H16N2O6
MF: 284.27
Purity: 95%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: PVPSBJHKGXULPJ-QCNRFFRDSA-N
CanonicalSMILES: C=CCOC1C(OC(C1O)N2CCC(=O)NC2=O)CO
IUPAC Name: 1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]-1,3-diazinane-2,4-dione
InChI: InChI=1S/C12H18N2O6/c1-2-5-19-10-7(6-15)20-11(9(10)17)14-4-3-8(16)13-12(14)18/h2,7,9-11,15,17H,1,3-6H2,(H,13,16,18)/t7-,9-,10-,11-/m1/s1
Synonyms: 3'-(O-allyl) Uridine; 3'-O-Allyl-D-uridine; 1-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

3'-O-Allylcytidine

Description: 3'-O-Allylcytidine, a cutting-edge biomedical innovation, stands as a pivotal resource in combating a wide range of diseases. It showcases an exquisite modification of cytidine, unveiling extraordinary potential in the selective eradication of cancerous cells and hindering their malignant proliferation. Furthermore, this compound's remarkable antiviral attributes have garnered significant attention, empowering its utilization against specific strains of viral infections.
CAT: BRP-01704
MF: C12H17N3O5
MF: 283.28
Purity: 98%
Size Price Stock Quantity
-- -- --
Inquiry   
InChIKey: SUDPDZLUFKFRMW-QCNRFFRDSA-N
CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=CC(=NC2=O)N)CO
IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C12H17N3O5/c1-2-5-19-10-7(6-16)20-11(9(10)17)15-4-3-8(13)14-12(15)18/h2-4,7,9-11,16-17H,1,5-6H2,(H2,13,14,18)/t7-,9-,10-,11-/m1/s1
Synonyms: 3'-O-Allyl-D-cytidine; 3'-(O-allyl) Cytidine; 1-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-aminopyrimidin-2(1H)-one
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket